Literature DB >> 32981925

Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.

Chun-Ka Wong1, Hayes Kam-Hei Luk2, Wing-Hon Lai1, Yee-Man Lau1, Ricky Ruiqi Zhang3, Antonio Cheuk-Pui Wong2, George Chi-Shing Lo2, Kwok-Hung Chan3, Ivan Fan-Ngai Hung3, Hung-Fat Tse1, Patrick Chiu-Yat Woo2, Susanna Kar-Pui Lau2, Chung-Wah Siu1.   

Abstract

BACKGROUND: SARS-CoV-2 infection is associated with myocardial injury, but there is a paucity of experimental platforms for the condition.Methods and 
Results: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) infected by SARS-CoV-2 for 3 days ceased beating and exhibited cytopathogenic changes with reduced viability. Active viral replication was evidenced by an increase in supernatant SARS-CoV-2 and the presence of SARS-CoV-2 nucleocaspid protein within hiPSC-CMs. Expressions of BNP, CXCL1, CXCL2, IL-6, IL-8 and TNF-α were upregulated, while ACE2 was downregulated.
CONCLUSIONS: Our hiPSC-CM-based in-vitro SARS-CoV-2 myocarditis model recapitulated the cytopathogenic effects and cytokine/chemokine response. It could be exploited as a drug screening platform.

Entities:  

Keywords:  COVID-19; Myocarditis; SARS-CoV-2; Stem cells

Mesh:

Substances:

Year:  2020        PMID: 32981925     DOI: 10.1253/circj.CJ-20-0881

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

1.  Stem Cells as a Model of Study of SARS-CoV-2 and COVID-19: A Systematic Review of the Literature.

Authors:  María Verónica Cuevas-Gonzalez; Álvaro Garcia-Perez; Álvaro Edgar Gonzalez-Aragon Pineda; León Francisco Espinosa-Cristobal; Alejandro Donohue-Cornejo; Karla Lizette Tovar-Carrillo; Rosa Alicia Saucedo-Acuña; Juan Carlos Cuevas-Gonzalez
Journal:  Biomed Res Int       Date:  2021-08-25       Impact factor: 3.411

Review 2.  Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.

Authors:  Tarek Khedro; Jason M Duran; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2022-06-03       Impact factor: 3.955

3.  SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics.

Authors:  Karthik Ramachandran; Soumya Maity; Alagar R Muthukumar; Soundarya Kandala; Dhanendra Tomar; Tarek Mohamed Abd El-Aziz; Cristel Allen; Yuyang Sun; Manigandan Venkatesan; Travis R Madaris; Kevin Chiem; Rachel Truitt; Neelanjan Vishnu; Gregory Aune; Allen Anderson; Luis Martinez; Wenli Yang; James D Stockand; Brij B Singh; Subramanya Srikantan; W Brian Reeves; Muniswamy Madesh
Journal:  iScience       Date:  2022-01-01

Review 4.  Hypertension and its management in COVID-19 patients: The assorted view.

Authors:  Gaber El-Saber Batiha; Abdulrahim Gari; Norhan Elshony; Hazem M Shaheen; Murtala Bello Abubakar; Sherif Babatunde Adeyemi; Hayder M Al-Kuraishy
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2021-11-13

5.  Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating.

Authors:  José Alexandre Salerno; Thayana Torquato; Jairo R Temerozo; Livia Goto-Silva; Karina Karmirian; Mayara A Mendes; Carolina Q Sacramento; Natalia Fintelman-Rodrigues; Letícia R Q Souza; Isis M Ornelas; Carla P Veríssimo; Luiz Guilherme H S Aragão; Gabriela Vitória; Carolina S G Pedrosa; Suelen da Silva Gomes Dias; Vinicius Cardoso Soares; Teresa Puig-Pijuan; Vinícius Salazar; Rafael Dariolli; Diogo Biagi; Daniel R Furtado; Luciana Barreto Chiarini; Helena L Borges; Patrícia T Bozza; Marilia Zaluar P Guimarães; Thiago M L Souza; Stevens K Rehen
Journal:  PeerJ       Date:  2021-12-20       Impact factor: 2.984

Review 6.  The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury.

Authors:  Bhurint Siripanthong; Babken Asatryan; Thomas C Hanff; Salman R Chatha; Mohammed Y Khanji; Fabrizio Ricci; Daniele Muser; Victor A Ferrari; Saman Nazarian; Pasquale Santangeli; Rajat Deo; Leslie T Cooper; Saidi A Mohiddin; C Anwar A Chahal
Journal:  JACC Basic Transl Sci       Date:  2022-02-09

Review 7.  COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.

Authors:  Berenice Martínez-Salazar; Melle Holwerda; Chiara Stüdle; Indre Piragyte; Nadia Mercader; Britta Engelhardt; Robert Rieben; Yvonne Döring
Journal:  Front Cell Dev Biol       Date:  2022-02-15

8.  Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes.

Authors:  Chun-Ka Wong; Yee-Man Lau; Wing-Hon Lai; Ricky-Ruiqi Zhang; Hayes Kam-Hei Luk; Antonio Cheuk-Pui Wong; Patrick Chiu-Yat Woo; Susanna Kar-Pui Lau; Kwok-Hung Chan; Ivan Fan-Ngai Hung; Chung-Wah Siu
Journal:  Cardiol J       Date:  2022-05-17       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.